Jignesh Upadhyay

Jignesh Upadhyay

Account Executive

Followers of Jignesh Upadhyay10 followers
location of Jignesh UpadhyayIndia

Connect with Jignesh Upadhyay to Send Message

Connect

Connect with Jignesh Upadhyay to Send Message

Connect
  • Timeline

  • About me

    Account Executive at Glenmark Life Sciences

  • Education

    • Centre for Financial Services

      2018 - 2018
      Vocational Diploma Goods and Services Tax
    • South Gujarat University

      1990 - 1993
      Bachelor of Commerce - BCom Accounting and Finance
  • Experience

    • Glenmark Life Sciences

      Oct 2007 - now
      Account Executive

      * GST Related Responsibilities -Service and material invoice review and initial approval as per GST Law.ITC reversal working on monthly basis as material destruction, free sample and handling lossAssets transfer, scrap assets sales invoice preparing.Intra Company invoice processing* Other Responsibilities :Monthly MIS details as – Scarp Ageing - RM-PM picking- RGP Future date –MIS scrap sales-Inward Date v/s. GRN DateMonthly expense provision detail with JVUnsettle Advances monitoring, AMC Invoices tracking and settlePhysical stock verification and Statuary stock audit attend 2 times in yearInventory detail as Block stock, Quality stock and restricted stock monthly detailMonitoring of Open PO/PR/GRN detail and follow up for settlePending Sales Tax Assessment activityProfessional Tax AssessmentAuditor for physical stock in the unitMonthly basis total inventory report data preparationFacilitator for VAT audit, sales tax assessment and other sales tax related work Show less

  • Licenses & Certifications

    • GST Returns 2021 Course (Ongoing)

      Udemy
      Jun 2021
      View certificate certificate
    • Business Communication Program

      Glenmark Life Sciences
      Jun 2009
    • Executive Development Program

      Glenmark Life Sciences
      Jul 2008
    • Analytical Skills & Decision Making Program

      Glenmark Life Sciences
      Aug 2009
    • Effective English Communication

      Glenmark Life Sciences
      Mar 2010